机构:[a]Department of Neurosurgery, First Affiliated Hospital, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, China外科系统神经外科浙江大学医学院附属第一医院[b]Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China研究所北京市神经外科研究所首都医科大学附属天坛医院[c]Department of General Surgery, First Affiliated Hospital, Zhejiang University, Hangzhou, China外科系统浙江大学医学院附属第一医院
Onyx is increasingly used in endovascular therapy of intracranial arteriovenous malformations (AVMs). However, the embolic effect and post-embolization management are still under discussion. We report our experience in the treatment of supratentorial brain arteriovenous malformations (SBAVMs) with Onyx and discuss post-embolic management. From June 2006 to July 2008, 20 patients with SBAVM were embolized with Onyx. There were 14 men and six women ranging from 14 to 64 years of age (mean 38.3 years). Initial symptoms included spontaneous hemorrhage (n=12), headaches (n=4), seizure (n=3) and incidentally disclosed after head trauma (n=l). After the endovascular procedure, all had subsequent treatment (follow-up angiogram, stereotactic radiosurgery or microsurgery) according to the obliteration degree. At angiography, seven patients (35%, 7/20) were completely obliterated (over 95% closure) after embolization while one suffered a small subarachnoid hemorrhage without permanent clinical sequelae. Four patients (20%, 4/20) were subtotally obliterated (over 80% closure), one patient who suffered severe cerebral edema after embolization underwent decompressive craniectomy, two patients had additional radiosurgery and one patient had follow-up angiogram. Nine patients (45%, 9/20) were partially obliterated (20-80% closure), five patients had additional surgery, two patients had additional radiosurgery and two patients had follow-up angiogram (one patient had intraventricular hemorrhage three months after embolization). Of all 20 AVMs, an average of 2.2 ml Onyx was used per patient and average volume reduction was 80% (range, 30%-99%). Onyx is suitable for embolization of SBAVMs because of its diffuse controllable properties. We suggest clinical follow-up after complete obliteration, additional radiosurgery or angiographic follow-up after subtotal obliteration and additional surgery after partially obliteration. More cases with long-term follow-up are needed to evaluate the long-term prognosis of our post-embolization management.
语种:
外文
中科院(CAS)分区:
出版当年[2008]版:
大类|4 区医学
小类|4 区临床神经病学4 区核医学
最新[2023]版:
无
第一作者:
推荐引用方式(GB/T 7714):
Pan J.W,Zhou H.J,Zhan R.-Y,et al.Supratentorial brain AVM embolization with Onyx-18 and post-embolization management: A single-center experience[J].2009,15(3):
APA:
Pan, J.W,Zhou, H.J,Zhan, R.-Y,Wan, S,Yan, M...&Zheng, S.S.(2009).Supratentorial brain AVM embolization with Onyx-18 and post-embolization management: A single-center experience.,15,(3)
MLA:
Pan, J.W,et al."Supratentorial brain AVM embolization with Onyx-18 and post-embolization management: A single-center experience". 15..3(2009)